Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Fisk

Showing results (91-100 of 186) with videos related to

Pageof 19
Sort By:
Neuroepidemiology|January 16, 2020
Interrogation of the Multiple Sclerosis Prodrome Using High-Dimensional Health DataYinshan Zhao, José M A Wijnands, Tanja Högg, et al.
Multiple Sclerosis and Related Disorders|August 26, 2018
Identifying optic neuritis and transverse myelitis using administrative dataRuth Ann Marrie, Okechukwu Ekuma, José M A Wijnands, et al.
Lancet Regional Health. Americas|January 25, 2024
Disease-modifying drugs, multiple sclerosis and infection-related healthcare use in British Columbia, Canada: a population-based studyJonas Graf, Huah Shin Ng, Feng Zhu, et al.
Multiple Sclerosis and Related Disorders|December 1, 2024
Anticonvulsant and gabapentinoids pharmacotherapy in the multiple sclerosis prodrome: A population-based matched cohort studyHimali Bergeron-Vitez, Fardowsa LA Yusuf, Feng Zhu, et al.
Neurology|January 5, 2024
Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis: A Multiregional Population-Based StudyHuah Shin Ng, Feng Zhu, Yinshan Zhao, et al.
Journal of Clinical Gastroenterology|September 19, 2023
Perceived Need for Mental Health Care in a Cohort of Persons With Inflammatory Bowel DiseaseCharles N Bernstein, Casandra Dolovich, Madelaine Prichodko, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2018
Five years before multiple sclerosis onset: Phenotyping the prodromeJosé Ma Wijnands, Feng Zhu, Elaine Kingwell, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 14, 2022
Disease-Modifying Drugs for Multiple Sclerosis and Association With SurvivalHuah Shin Ng, Feng Zhu, Elaine Kingwell, et al.
Scientific Reports|December 1, 2023
Multiple sclerosis disease-modifying drug use by immigrants: a real-world studyJonas Graf, Huah Shin Ng, Feng Zhu, et al.
Multiple Sclerosis and Related Disorders|July 19, 2019
Higher health care use before a clinically isolated syndrome with or without subsequent MSRuth Ann Marrie, José M A Wijnands, Elaine Kingwell, et al.
Pageof 19

Showing results (91-100 of 186) with videos related to

Sort By:
Pageof 19
Neuroepidemiology|January 16, 2020
Interrogation of the Multiple Sclerosis Prodrome Using High-Dimensional Health DataYinshan Zhao, José M A Wijnands, Tanja Högg, et al.
Multiple Sclerosis and Related Disorders|August 26, 2018
Identifying optic neuritis and transverse myelitis using administrative dataRuth Ann Marrie, Okechukwu Ekuma, José M A Wijnands, et al.
Lancet Regional Health. Americas|January 25, 2024
Disease-modifying drugs, multiple sclerosis and infection-related healthcare use in British Columbia, Canada: a population-based studyJonas Graf, Huah Shin Ng, Feng Zhu, et al.
Multiple Sclerosis and Related Disorders|December 1, 2024
Anticonvulsant and gabapentinoids pharmacotherapy in the multiple sclerosis prodrome: A population-based matched cohort studyHimali Bergeron-Vitez, Fardowsa LA Yusuf, Feng Zhu, et al.
Neurology|January 5, 2024
Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis: A Multiregional Population-Based StudyHuah Shin Ng, Feng Zhu, Yinshan Zhao, et al.
Journal of Clinical Gastroenterology|September 19, 2023
Perceived Need for Mental Health Care in a Cohort of Persons With Inflammatory Bowel DiseaseCharles N Bernstein, Casandra Dolovich, Madelaine Prichodko, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2018
Five years before multiple sclerosis onset: Phenotyping the prodromeJosé Ma Wijnands, Feng Zhu, Elaine Kingwell, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 14, 2022
Disease-Modifying Drugs for Multiple Sclerosis and Association With SurvivalHuah Shin Ng, Feng Zhu, Elaine Kingwell, et al.
Scientific Reports|December 1, 2023
Multiple sclerosis disease-modifying drug use by immigrants: a real-world studyJonas Graf, Huah Shin Ng, Feng Zhu, et al.
Multiple Sclerosis and Related Disorders|July 19, 2019
Higher health care use before a clinically isolated syndrome with or without subsequent MSRuth Ann Marrie, José M A Wijnands, Elaine Kingwell, et al.
Pageof 19